1. SEER*Explorer. SEER Cancer Statistics. National Cancer Institute. Published April 19, 2023. Accessed October 30, 2023. https://seer.cancer.gov/statistics-network/explorer/.
2. Real-world survival outcomes associated with first-line immunotherapy, targeted therapy, and combination therapy for metastatic clear cell renal cell carcinoma;Chakiryan;JAMA Netw Open,2021
3. Cancer statistics, 2023;Siegel;CA Cancer J Clin,2023
4. Immunotherapies in genitourinary oncology: Where are we now? Where are we going?;Jang;Cancers,2021
5. Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: A single-arm, multicentre, phase 2 trial;Balar;Lancet Lond Engl,2017